Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|August 29, 2019
- Pharmaceutical Technology\'s In the Lab eNewsletter-09-04-2019
- Volume 14
- Issue 9
Zeiss Unveils New Ion Beam Microscope Capabilities
The updated microscopes will cover a wider range of tasks across analytics, tomography, sample preparation, and data integrity.
Advertisement
Zeiss, an optics and optoelectronics technology enterprise company, introduced additional functions for its Zeiss ion beam microscopes, making the devices capable of handling engineering materials, energy materials, soft materials, geosciences covering megatrends in additive manufacturing, etc. for analytics, tomography, sample preparation, and data integrity.
The microscopes will be equipped with secondary ion mass spectrometry solutions for elemental analysis and time-of-flight secondary ion mass spectrometry detection for analytical purposes. Along with this, the tomography functions of the microscopes will be enhanced by workflows for 3D tomography to ensure quality 3D data volume generation with quantified and calibrated measurement of z-slice thickness for reconstruction of tomogram slices into a reconstructed volume.
A new loading station and sample holder for transmission electron microscopy (TEM) lamella preparation leads to an easier transition of the sample to the TEM for further analysis. Data integrity is also enhanced with ZEISS ZEN Intellesis, a machine learning-based segmentation software that ensures data integrity is maintained as data acquisition speed and quality are improved.
Source:
Articles in this issue
about 7 years ago
Predictive Digital Twins Control Bioprocesses for MAb Productionabout 7 years ago
New Cell Cultureware Enhances Stem Cell Expansionabout 7 years ago
New Cell Cultureware Enhances Stem Cell Expansionabout 7 years ago
Thermo Fisher Scientific Introduces a New Krios Solutionabout 7 years ago
Drugscan Develops Method to Evaluate Transdermal Patch Capabilitiesabout 7 years ago
EAG Launches New Lab in China for Product Improvementabout 7 years ago
Olympus to Present Light Microscopy AwardAdvertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement